NCT07454668 2026-03-06Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain MetastasesBaptist Health South FloridaPhase 1 Not yet recruiting20 enrolled
NCT02564900 2024-01-22Study of DS-8201a in Subjects With Advanced Solid Malignant TumorsDaiichi SankyoPhase 1 Completed292 enrolled 35 charts 1 FDA
NCT03383692 2023-12-11Study of DS-8201a for Participants With Advanced Solid Malignant TumorsDaiichi SankyoPhase 1 Completed40 enrolled 20 charts
NCT03368196 2022-11-03DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) ProteinDaiichi SankyoPhase 1 Completed12 enrolled 15 charts